Carbon Neutral Action Plan, Targets and Progress

The Pharmaceutical Manufacturers Association of Japan (PMAJ) participates in the Environmental Committee of the Federation of Pharmaceutical Manufacturers' Associations of Japan (JFPMA).
The committee has two working groups working on the Carbon Neutral Action Plan and the Voluntary Action Plan for Establishing a Recycling-Oriented Society, and this page introduces the activities of the former and the status of response by the member companies of the Pharmaceutical Manufacturers Association of Japan.

Carbon Neutral Action Plan

Carbon Neutral Action Plan

Status of member companies' vision setting/target setting toward "carbon neutrality in 2050" (as of October 2023)

  • As of December 2023
    For member companies that disclose information on their websites, a link is provided in the company name.
Member Company Name Vision Goal setting
Asahi Kasei Pharma Corporation Supported Supported
Asuka Pharmaceuticals, Inc. Supported Supported
Astellas Pharma Inc. Supported Supported
AstraZeneca Corporation Supported Supported
Amgen K.K. Supported Supported
Alfresa Pharma Corporation Supported Supported
EA Pharma Corporation Supported Supported
Viatris Pharmaceuticals, LLC Supported Supported
Eisai Co. Supported Supported
MSD Corporation Supported Supported
Otsuka Pharmaceutical Co. Supported Supported
Ono Pharmaceutical Co. Supported Supported
Kaken Pharmaceutical Co. Supported Supported
Kissei Pharmaceutical Co. Supported Supported
Kyoto Pharmaceutical Industry Co. Supported Supported
Kyorin Pharmaceutical Co. Supported Supported
Kyowa Kirin Company, Limited Supported Supported
GlaxoSmithKline K.K. Supported Supported
KM Biologics K.K. Supported Supported
sanofi corporation Supported Supported
Santen Corporation Supported Supported
Shionogi & Co. Supported Supported
Sumitomo Pharma Co. Supported Supported
Seikagaku Kogyo Co. Supported Supported
Daiichi Sankyo Company, Limited Supported Supported
Taisho Pharmaceutical Co. Supported Supported
Taiho Pharmaceutical Co. Supported Supported
Takeda Pharmaceutical Company Limited Supported Supported
Tanabe Pharma K.K. Supported Supported
Chugai Pharmaceutical Co. Supported Supported
Tsumura Corporation Supported Supported
Teijin Pharma Limited Supported Supported
Toa Eiyo Co. Supported Supported
Torii Pharmaceuticals Co. Supported Supported
Nippon Kayaku Co. Supported Not supported
Nippon Shinyaku Co. Supported Supported
Nippon Boehringer Ingelheim Co. Supported Supported
Nippon Zoki Pharmaceutical Co. Supported Not supported
Novartis Pharma K.K. Supported Supported
Novo Nordisk Pharma K.K. Supported Supported
Bayer Yakuhin K.K. Supported Supported
Vigene Japan K.K. Supported Supported
Pfizer Japan Inc. Supported Supported
Fujifilm Toyama Chemical Co. Supported Supported
Maruho Co. Supported Supported
Meiji Seika Pharma Co. Supported Supported
Merck Biopharma K.K. Supported Supported
Mochida Pharmaceutical Co. Supported Supported
Janssen Pharma K.K. Supported Supported

Share this page

TOP